Tom Lloyd received a BSN degree from the University of Florida and an MS degree from the Nurse-Midwifery Tract, University of Utah. He has practiced nurse-midwifery in Florida, Utah, and Oregon in a variety of settings. He currently serves as an Assistant Professor in the Women's Health Care/Nurse-Midwifery Program at Oregon Health Sciences University in Portland, where he teaches and practices.
A Primer for Prevention
Version of Record online: 6 JAN 2011
1987 American College of Nurse Midwives
Journal of Nurse-Midwifery
Volume 32, Issue 5, pages 297–307, September-October 1987
How to Cite
Lloyd, T. (1987), Rh-FACTOR INCOMPATIBILITY. Journal of Nurse-Midwifery, 32: 297–307. doi: 10.1016/0091-2182(87)90024-3
- Issue online: 6 JAN 2011
- Version of Record online: 6 JAN 2011
The history of the Rh problem is largely one of success. In some communities the incidence of hemolytic disease due to Rh-incompatibility approaches an irreducible minimum. Efforts to further decrease the pathology that results from Rh-incompatibility continue on two fronts: prevention of maternal sensitization and in utero treatment of the affected fetus. Unfortunately, while the controversy continues regarding the cost-effectiveness of routine antepartal administration of Rh immune globulin, many sensitizations still occur as a result of practitioner error. On the other front, technical advances in ultrasonography are assisting perinatologists in more direct treatment of affected fetuses. Nurse-midwives will continue to play a role in the prevention of sensitization through proper screening and follow-up of their Rh-negative clients. Education and direct involvement of the Rh-negative client in avoiding sensitization may be a first step in the prevention process.